Literature DB >> 1422718

Symptom index as a marker of gastro-oesophageal reflux disease.

B T Johnston1, R J McFarland, J S Collins, A H Love.   

Abstract

Forty per cent of patients with heartburn may have no evidence of oesophagitis or of abnormal oesophageal acid exposure. The symptom index correlates symptoms that occur during pH monitoring with episodes of acid reflux, being the number of symptoms during reflux divided by the total number occurring during monitoring. This index was assessed in 61 patients with heartburn. In 39 patients with endoscopic evidence of oesophagitis or abnormal acid exposure times on pH monitoring, the symptom index had a sensitivity of 90 per cent. Of the 22 patients with no objective abnormality, the index was > or = 50 per cent in five (23 per cent) whose symptoms were presumably due to acid reflux despite results of other investigations being normal, suggesting an acid-sensitive oesophagus. The symptom index is a useful additional measure in the investigation of patients with suspected gastro-oesophageal reflux disease.

Entities:  

Mesh:

Year:  1992        PMID: 1422718     DOI: 10.1002/bjs.1800791022

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  17 in total

1.  What is heartburn worth? A cost-utility analysis of management strategies.

Authors:  G R Heudebert; R M Centor; J C Klapow; R Marks; L Johnson; C M Wilcox
Journal:  J Gen Intern Med       Date:  2000-03       Impact factor: 5.128

Review 2.  Cough. 3: chronic cough and gastro-oesophageal reflux.

Authors:  G A Fontana; M Pistolesi
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

3.  Most GERD symptoms are not due to acid reflux in patients with very low 24-hour acid contact times.

Authors:  Bryan T Green; J Barry O'Connor
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

4.  Validity of endoscopic classification of nonerosive reflux disease.

Authors:  Takashi Joh; Hiroto Miwa; Kazuhide Higuchi; Tomohiko Shimatani; Noriaki Manabe; Kyoichi Adachi; Tsuneya Wada; Makoto Sasaki; Yasuhiro Fujiwara; Michio Hongo; Tsutomu Chiba; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

5.  Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus".

Authors:  R G Watson; T C Tham; B T Johnston; N I McDougall
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

6.  Increased tachykinin levels in induced sputum from asthmatic and cough patients with acid reflux.

Authors:  Robert N Patterson; Brian T Johnston; Joy E S Ardill; Liam G Heaney; Lorcan P A McGarvey
Journal:  Thorax       Date:  2007-01-24       Impact factor: 9.139

Review 7.  Guide to the use of proton pump inhibitors in adult patients.

Authors:  Vandana Boparai; Jaishree Rajagopalan; George Triadafilopoulos
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 8.  Diagnosis of reflux disease.

Authors:  N I McDougall
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

9.  Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study.

Authors:  Kiyoshi Ashida; Yoshikazu Kinoshita; Michio Hongo
Journal:  Dig Dis Sci       Date:  2011-02-08       Impact factor: 3.199

10.  Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol.

Authors:  L G Heaney; E Conway; C Kelly; B T Johnston; C English; M Stevenson; J Gamble
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.